The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
8 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,160,483 in first-year total cost, median $254,914.
Most frequent study sections
- Special Emphasis Panel[ZDA1 SXC-G (J2)]3
- Special Emphasis Panel[ZDA1 SUY-E (O1)]2
- Special Emphasis Panel[ZDA1 SUY-E (J1)]1
- Special Emphasis Panel[ZDA1 SUY-E (M1)]1
- Special Emphasis Panel[ZDA1 SXC-G (20)]1
Most frequent institutions
- BRANDEIS UNIVERSITY1
- FRIENDS RESEARCH INSTITUTE, INC.1
- JOHNS HOPKINS UNIVERSITY1
- NEW YORK UNIVERSITY SCHOOL OF MEDICINE1
- NORTHWESTERN UNIVERSITY AT CHICAGO1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2025 | Leveraging a time-limited opportunity to study the impact of an intervention for individuals bereaved by drug overdose1R21DA062508-01 | HOCHSTATTER, KARLI RAE | FRIENDS RESEARCH INSTITUTE, INC., MD | $197,250 | ZDA1 |
| 2024 | A National Survey on Naloxone Use and Access1R21DA060711-01 | POWELL, DAVID | RAND CORPORATION, CA | $424,545 | ZDA1 |
| 2024 | Simulating the Impact of Office-Based Methadone Prescribing and Pharmacy Dispensing on OUD Treatment and Overdose in New York State: An Agent-Based Modeling Approach1R21DA061660-01 | JORDAN, ASHLY ELIZABETHKRAWCZYK, NOA | NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY | $227,861 | ZDA1 |
| 2023 | Rapid Research for Xylazine Response1R21DA060056-01 | GENBERG, BECKY LYNNGERMAN, DANIELLE | JOHNS HOPKINS UNIVERSITY, MD | $327,500 | ZDA1 |
| 2023 | Rapid measurement of novel harm reduction housing on HIV risk, treatment uptake, drug use and supply1R21DA058581-01 | GREEN, TRACI C | BRANDEIS UNIVERSITY, MA | $263,287 | ZDA1 |
| 2023 | Leveraging state drug overdose data to build a comprehensive case level national dataset to inform prevention and mitigation strategies.1R21DA058583-01 | POST, LORI ANN | NORTHWESTERN UNIVERSITY AT CHICAGO, IL | $259,606 | ZDA1 |
| 2023 | Community-informed approaches to the escalating presence of xylazine in opioids1R21DA058582-01 | REED, MEGAN | THOMAS JEFFERSON UNIVERSITY, PA | $210,213 | ZDA1 |
| 2022 | Evaluating the decriminalization of non-prescribed buprenorphine in Rhode Island1R21DA057171-01 | DEL POZO, BRANDONRICH, JOSIAH D | RHODE ISLAND HOSPITAL, RI | $250,221 | ZDA1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.